Shanxi Zhendong Pharmaceutical Co.,Ltd (SHE:300158)

China · Delayed Price · Currency is CNY

5.25

-0.14 (-2.60%)

Sep 10, 2026, 12:15 PM CST

SHE:300158 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Revenue	2,423	2,783	2,971	3,626	3,729	5,094
Revenue Growth	-17.08%	-6.33%	-18.06%	-2.75%	-26.80%	5.07%
Gross Profit	1,231	1,394	1,159	1,796	1,834	3,036
Operating Income	-383.52	-303.32	-634.14	-99.52	-114.52	148.84
Net Income	-401.72	-301.06	-1,329	-43.98	-51.29	2,617
Earnings Per Share	-0.41	-0.30	-1.30	-0.04	-0.05	2.55
EPS Growth	-	-	-	-	-	898.98%

Revenue by Segment

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Pharmaceutical Production and Sales	3,201
Chinese Herbal Medicine Cultivation	865.38
Research and Development	104.94
Offset of Business Segment	-1,388
Total	2,783

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Investments	722.87	1,002	1,579	2,249	2,740	5,692
Total Debt	223.46	184.63	41.39	3.03	21.87	312.72
Net Cash (Debt)	499.41	817.23	1,538	2,246	2,718	5,379
Net Cash Growth	-51.39%	-46.86%	-31.52%	-17.36%	-49.48%	1003.25%
Net Cash Per Share	0.51	0.81	1.50	2.19	2.64	5.24

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Operating Cash Flow	-405.43	-460.48	-149.82	-249.17	81.32	284.45
Capital Expenditures	-146.56	-179.12	-298.48	-116.21	-145.81	-151.66
Free Cash Flow	-551.99	-639.6	-448.3	-365.39	-64.49	132.79
Free Cash Flow Growth	-	-	-	-	-	249.58%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Gross Margin	50.81%	50.08%	39.00%	49.54%	49.20%	59.60%
Operating Margin	-15.83%	-10.90%	-21.34%	-2.74%	-3.07%	2.92%
Pretax Margin	-16.33%	-9.98%	-44.26%	-1.04%	-0.14%	61.18%
Profit Margin	-16.58%	-10.82%	-44.72%	-1.21%	-1.38%	51.39%
FCF Margin	-22.79%	-22.98%	-15.09%	-10.08%	-1.73%	2.61%

Dividends

Fiscal Year	FY 2021
Period Ending	Jan '22 Jan 1, 2022
Dividend Per Share	2.800
Dividend Per Share Growth	3900.00%
Dividend Yield	44.90%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
PE Ratio	-	-	-	-	-	3.22
Forward PE	-	12.38	12.38	12.38	12.38	12.38
P/FCF Ratio	-	-	-	-	-	63.37
PS Ratio	2.21	2.07	1.46	1.91	2.05	1.65